Clinical Trial

Diaphragmatic Function as a Biomarker

Study acronym: DFUNBIO
Recruiting
View on ClinicalTrials.gov →
Summary
Dyspnea is among the most common symptoms in patients with respiratory diseases such as Asthma, chronic obstructive pulmonary disease (COPD), Fibrosis, and Pulmonary Hypertension. However, the pathophysiology and underlying mechanisms of dyspnea in patients with respiratory diseases are still poorly understood. Diaphragm dysfunction might be highly prevalent in patients with dyspnea and respiratory diseases. The association of diaphragm function and potential prognostic significance in patients with respiratory diseases has not yet been investigated.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2023-06-05; most recent amendment 2026-01-26.
Status change: Not Yet Recruiting → Recruiting 2023-11-21
Trial Details
NCT Number NCT05903001
Lead Sponsor RWTH Aachen University
Conditions Dyspnea; Asthmatic, COPD, Fibrosis, Pulmonary Hypertension, Asthma, Dyspnea
Enrollment 800 participants
Start Date 2023-07-01
Primary Completion 2026-12-30 (estimated)
Study Completion 2026-12-30 (estimated)
Updated on ClinicalTrials.gov 2026-01-28